Medimix International To Exhibit At American Society of Clinical Oncology AGM
Main Category: Cancer / OncologyArticle Date: 26 May 2009 - 5:00 PDT
'Medimix International To Exhibit At American Society of Clinical Oncology AGM'
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
1 (1 votes) |
Medimix International, a leader in global healthcare marketing research for life sciences industry, announced that it will be exhibiting at the 45th AGM of the American Society of Clinical Oncology, which will take place in Orlando, Florida from May 29-June 2, 2009. The annual ASCO meeting is considered to be the premier educational and scientific event in the oncology community, a forum for cutting-edge scientific and educational developments in oncology with a focus on personalizing cancer care.
Medimix International has a long history of working in the field of oncology/hematology, one of its key therapeutic areas, and in fact around 35-40% of its yearly projects are conducted in that field. It currently manages a panel of more than 17,000 oncologists and over 13,000 hematologists from North America, Europe, Asia, Latin America, and the Middle East. Specialties included in the panel are medical, radiation, surgical, gynecology, and pediatric oncology, with Medimix's demonstrating particular expertise in the areas of anemia, breast, lung, bowel, prostate, and renal cancers.
"Oncology is a very challenging field where treatment options are continuously evolving," commented Dr. Tessa Schoor, Medimix's Chief Medical Officer. "It is crucial for us to stay up to date on the new therapeutic outcomes that are discussed at the ASCO meeting every year. "
With over 26,000 professionals from 128 countries attending the ASCO event, Medimix's presence will have a dual purpose: to extend an invitation to these experts to become part of its new online community and to showcase its services to clients in the pharmaceutical, medical device and biotechnology fields.
"Over 53% of visitors at ASCO come from outside the United States," noted Henry Gazay, CEO of Medimix International. "The reach of our onco/hematology panel being global, exhibiting at ASCO represents a unique opportunity to meet some of the key members of our community from diverse countries around the world. Physicians and KOLs will come to our booth to share their experience of working with us and working together. It is also a great opportunity to show new marketing services to our clients."
Medimix International will be present at the ASCO exhibition, May 29- June 1, booth #426
Source
Medimix International
Visit our cancer / oncology section for the latest news on this subject.
MLA
24 May. 2012. <http://www.medicalnewstoday.com/releases/151399.php>
APA
http://www.medicalnewstoday.com/releases/151399.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Medimix International To Exhibit At American Society of Clinical Oncology AGM'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





